Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies

Massimo De Paschale; Luisa Belvisi; Debora Cagnin; Teresa Cerulli; Maria Teresa Manco; Laura Marinoni; Alessia Paganini; Pierangelo Clerici

doi:10.4081/mm.2008.2584

Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies

https://doi.org/10.4081/mm.2008.2584

PDF

Vol. 23 No. 2 (2008)

Submitted: 17 February 2014
Accepted: 17 February 2014

Published: 30 June 2008

External quality control, IgM anti-Mycoplasma

Abstract Views: 887

PDF: 790

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We evaluated the correlation among four commercial ELISA tests for the presence of anti-Mycoplasma pneumoniae IgM antibodies in 36 samples obtained from patients with respiratory infections.The overall concordance among the four tests was 30%, while the one among single tests varies from 39% to 75%. Given the variability of the results, it is necessary to implement a External Quality Control specific for anti-Mycoplasma pneumoniae IgM antibodies.

De Paschale, M., Belvisi, L., Cagnin, D., Cerulli, T., Manco, M. T., Marinoni, L., Paganini, A., & Clerici, P. (2008). Necessity of External Quality Control for anti-Mycoplasma pneumoniae IgM antibodies. Microbiologia Medica, 23(2). https://doi.org/10.4081/mm.2008.2584